| Product Code: ETC13372887 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Shingles Vaccines Market was valued at USD 3.4 Billion in 2024 and is expected to reach USD 5.8 Billion by 2031, growing at a compound annual growth rate of 4.70% during the forecast period (2025-2031).
The Global Shingles Vaccines Market is witnessing steady growth due to the rising prevalence of herpes zoster, also known as shingles, particularly among the elderly population. The market is driven by the increasing awareness about the importance of vaccination in preventing shingles and its complications. Key players in the market are continuously investing in research and development activities to introduce innovative vaccines and expand their product portfolios. Furthermore, government initiatives and vaccination programs aimed at reducing the burden of shingles are also contributing to market growth. North America holds a significant market share due to the high adoption rate of shingles vaccines in the region. The market is expected to continue growing as the aging population increases globally, leading to a higher demand for shingles vaccines.
The Global Shingles Vaccines Market is experiencing significant growth due to the increasing awareness about the importance of vaccination in preventing shingles, a painful viral infection. The market is driven by the rising geriatric population, who are at a higher risk of developing shingles, as well as the growing adoption of preventive healthcare measures. Additionally, advancements in vaccine technology and the development of new and improved shingles vaccines are further fueling market growth. Opportunities in this market include expanding into emerging economies with growing healthcare infrastructure, launching innovative vaccine formulations, and focusing on collaborations and partnerships for research and development. Overall, the Global Shingles Vaccines Market is poised for continued expansion and presents promising prospects for vaccine manufacturers and healthcare providers.
The Global Shingles Vaccines Market faces several challenges, including limited awareness among the general population about the importance of vaccination against shingles, leading to low vaccination rates. Additionally, the high cost of shingles vaccines and inadequate reimbursement policies in certain regions hinder widespread adoption. Supply chain issues and distribution challenges also impact the availability and accessibility of shingles vaccines in some areas. Furthermore, the complex dosing schedule of some shingles vaccines poses a barrier to compliance, affecting the overall effectiveness of vaccination programs. Overcoming these challenges requires concerted efforts from healthcare providers, policymakers, and pharmaceutical companies to increase awareness, improve access, and address affordability issues in order to effectively combat the burden of shingles globally.
The Global Shingles Vaccines Market is primarily driven by the increasing incidence of shingles among the aging population, growing awareness about the importance of vaccination in preventing shingles and its complications, and the continuous efforts by healthcare authorities to promote vaccination programs. Additionally, the rising healthcare expenditure and advancements in vaccine technology are also contributing to the market growth. The demand for shingles vaccines is expected to further increase due to the expanding geriatric population globally and the growing emphasis on preventive healthcare measures. Moreover, the availability of government initiatives and reimbursement policies for vaccination programs is anticipated to drive market growth in the forecast period.
Government policies related to the Global Shingles Vaccines Market vary across countries, with some providing subsidies or incentives to promote vaccination, while others have implemented mandatory vaccination programs for certain age groups. In the United States, the Centers for Disease Control and Prevention (CDC) recommends shingles vaccination for individuals aged 50 and older, with insurance coverage through Medicare Part D and private health plans. In countries like the UK, shingles vaccination is offered to individuals aged 70-79 through the National Health Service (NHS) immunization program. Overall, government policies aim to increase vaccination rates, reduce the burden of shingles-related healthcare costs, and prevent complications associated with the disease, aligning with public health goals to protect individuals from shingles and its consequences.
The Global Shingles Vaccines Market is poised for significant growth in the coming years due to the increasing awareness about the importance of vaccination in preventing shingles and its complications. Factors such as the rising geriatric population, higher incidence of shingles cases, and the development of advanced vaccines are expected to drive market expansion. Additionally, government initiatives and healthcare policies promoting vaccination programs are likely to further boost market growth. With ongoing research and development efforts focused on improving vaccine efficacy and accessibility, the market is projected to witness steady growth and innovation in the upcoming years. Overall, the future outlook for the Global Shingles Vaccines Market appears promising, with opportunities for market players to capitalize on the growing demand for effective shingles prevention solutions.
In the global shingles vaccines market, North America holds the largest share due to high awareness about vaccination benefits and a growing elderly population. Europe follows closely behind, driven by government initiatives to promote adult immunization. Asia Pacific is expected to witness significant growth, attributed to increasing healthcare infrastructure investments and rising awareness about preventive healthcare. The Middle East and Africa region is also showing steady growth, supported by improving access to healthcare services. Latin America is projected to experience a rise in demand for shingles vaccines due to expanding vaccination programs and a growing geriatric population. Overall, the global shingles vaccines market is expanding across all regions, driven by increasing emphasis on preventive healthcare and the rising burden of shingles-related complications.
Global Shingles Vaccines Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Shingles Vaccines Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Shingles Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Global Shingles Vaccines Market - Industry Life Cycle |
3.4 Global Shingles Vaccines Market - Porter's Five Forces |
3.5 Global Shingles Vaccines Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Shingles Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Shingles Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Global Shingles Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Global Shingles Vaccines Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Global Shingles Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Shingles Vaccines Market Trends |
6 Global Shingles Vaccines Market, 2021 - 2031 |
6.1 Global Shingles Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Shingles Vaccines Market, Revenues & Volume, By Live Attenuated, 2021 - 2031 |
6.1.3 Global Shingles Vaccines Market, Revenues & Volume, By Inactivated, 2021 - 2031 |
6.1.4 Global Shingles Vaccines Market, Revenues & Volume, By Combination, 2021 - 2031 |
6.2 Global Shingles Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Shingles Vaccines Market, Revenues & Volume, By Recombinant, 2021 - 2031 |
6.2.3 Global Shingles Vaccines Market, Revenues & Volume, By Viral Vector, 2021 - 2031 |
6.2.4 Global Shingles Vaccines Market, Revenues & Volume, By mRNA-Based, 2021 - 2031 |
6.2.5 Global Shingles Vaccines Market, Revenues & Volume, By Adjuvanted, 2021 - 2031 |
6.3 Global Shingles Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Shingles Vaccines Market, Revenues & Volume, By Immunization, 2021 - 2031 |
6.3.3 Global Shingles Vaccines Market, Revenues & Volume, By Postherpetic Neuralgia Prevention, 2021 - 2031 |
6.3.4 Global Shingles Vaccines Market, Revenues & Volume, By Elderly Population, 2021 - 2031 |
6.3.5 Global Shingles Vaccines Market, Revenues & Volume, By Immune Response Boosting, 2021 - 2031 |
6.3.6 Global Shingles Vaccines Market, Revenues & Volume, By General Population, 2021 - 2031 |
6.4 Global Shingles Vaccines Market, Revenues & Volume, By End Use, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Shingles Vaccines Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Global Shingles Vaccines Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4.4 Global Shingles Vaccines Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.4.5 Global Shingles Vaccines Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
6.4.6 Global Shingles Vaccines Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
7 North America Shingles Vaccines Market, Overview & Analysis |
7.1 North America Shingles Vaccines Market Revenues & Volume, 2021 - 2031 |
7.2 North America Shingles Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Shingles Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Shingles Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5 North America Shingles Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
7.6 North America Shingles Vaccines Market, Revenues & Volume, By End Use, 2021 - 2031 |
8 Latin America (LATAM) Shingles Vaccines Market, Overview & Analysis |
8.1 Latin America (LATAM) Shingles Vaccines Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Shingles Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Shingles Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Shingles Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
8.5 Latin America (LATAM) Shingles Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
8.6 Latin America (LATAM) Shingles Vaccines Market, Revenues & Volume, By End Use, 2021 - 2031 |
9 Asia Shingles Vaccines Market, Overview & Analysis |
9.1 Asia Shingles Vaccines Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Shingles Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Shingles Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Shingles Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
9.5 Asia Shingles Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
9.6 Asia Shingles Vaccines Market, Revenues & Volume, By End Use, 2021 - 2031 |
10 Africa Shingles Vaccines Market, Overview & Analysis |
10.1 Africa Shingles Vaccines Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Shingles Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Shingles Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Shingles Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
10.5 Africa Shingles Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
10.6 Africa Shingles Vaccines Market, Revenues & Volume, By End Use, 2021 - 2031 |
11 Europe Shingles Vaccines Market, Overview & Analysis |
11.1 Europe Shingles Vaccines Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Shingles Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Shingles Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Shingles Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
11.5 Europe Shingles Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
11.6 Europe Shingles Vaccines Market, Revenues & Volume, By End Use, 2021 - 2031 |
12 Middle East Shingles Vaccines Market, Overview & Analysis |
12.1 Middle East Shingles Vaccines Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Shingles Vaccines Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Shingles Vaccines Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Shingles Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Shingles Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
12.5 Middle East Shingles Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
12.6 Middle East Shingles Vaccines Market, Revenues & Volume, By End Use, 2021 - 2031 |
13 Global Shingles Vaccines Market Key Performance Indicators |
14 Global Shingles Vaccines Market - Export/Import By Countries Assessment |
15 Global Shingles Vaccines Market - Opportunity Assessment |
15.1 Global Shingles Vaccines Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Shingles Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Shingles Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
15.4 Global Shingles Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
15.5 Global Shingles Vaccines Market Opportunity Assessment, By End Use, 2021 & 2031F |
16 Global Shingles Vaccines Market - Competitive Landscape |
16.1 Global Shingles Vaccines Market Revenue Share, By Companies, 2024 |
16.2 Global Shingles Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here